FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Alternative Tools Let FDA Slash Preapproval Inspections by 55%

CDER Office of Pharmaceutical Manufacturing Assessment director Stelios C. Tsinontides says FDAs need to conduct preapproval inspections was reduced b...

Federal Register

Two Biological Products Reporting Exemption

Federal Register proposed order: FDA proposes to exempt certain blood and blood components for transfusion and cell and gene therapy products from ann...

Human Drugs

WLF Asks Court to Uphold Labeling Preemption

Washington Legal Foundation says the 9th Circuit Court of Appeals should uphold a lower court multi-district litigation decision that federal law pree...

New Final Rule Expands Intended Use Definition: Attorneys

Sidley attorneys say a new FDA final rule expands the ways the agency determines whether a consumer product is intended for drug or medical device use...

Human Drugs

Expand Draft Guidance on BE Studies in ANDAs: AAM

The Association for Accessible Medicines recommends broadening an FDA draft guidance on some ANDA bioequivalence studies.

Medical Devices

LDT Oversight Legislation Needed: Pew Research

The Pew Charitable Trusts say Congress should give FDA authority to regulate some higher-risk laboratory-developed tests.

Biologics

Panel Backs Pfizer Vaccine in Younger Kids

FDAs Vaccines and Related Biological Products Advisory Committee votes to recommend the agency authorize the use of Pfizers Covid-19 lower-dose vaccin...

Federal Register

OMB Info Collection on Drug Registration

Federal Register notice: FDA sends to OMB an information collection revision entitled Registration of Producers of Drugs and Listing of Drugs in Comme...

Medical Devices

Eyenovia Complete Response Related to Genus Decision

Eyenovia receives a complete response letter on its NDA for MydCombi (tropicamide and phenylephrine), indicated for in-office pupil dilation, because ...

Human Drugs

Alkermes Gets Fast Track on Ovarian Cancer Therapy

FDA grants Alkermes a fast track designation for nemvaleukin alfa, an engineered interleukin-2 variant immunotherapy for use in combination with Merck...